Wed, March 24, 2021
Tue, March 23, 2021
Mon, March 22, 2021

Ed Arce Maintained (AKRO) at Strong Buy with Increased Target to $68 on, Mar 23rd, 2021

Ed Arce of HC Wainwright & Co., Maintained "Akero Therapeutics, Inc." (AKRO) at Strong Buy with Increased Target from $61 to $68 on, Mar 23rd, 2021.

Ed has made no other calls on AKRO in the last 4 months.



There are 3 other peers that have a rating on AKRO. Out of the 3 peers that are also analyzing AKRO, 0 agree with Ed's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Ed


  • Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $46 on, Thursday, March 18th, 2021
  • Michael Morabito of "Chardan Capital" Maintained at Strong Buy with Increased Target to $81 on, Wednesday, March 17th, 2021
  • Etzer Darout of "Guggenheim" Initiated at Strong Buy and Held Target at $54 on, Friday, February 26th, 2021